OPKO Renal

Developing novel therapies to treat secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Renal Division of OPKO Health, Inc.

focused on developing proprietary products to treat secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). We are proud of our lead nephrology product, Rayaldee® (calcifediol) extended-release capsules, launched in 2016. In addition, the Renal Division is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients. OPKO’s expertise in Vitamin D chemistry, biochemistry, metabolism and physiology, combined with its experience in successfully bringing Vitamin D therapeutics to market uniquely positions the Renal Division to improve the lives of CKD patients.

11/27/2025

To all the nurses, physicians, dietitians, and family members supporting people living with CKD, your compassion sustains more than health. Happy Thanksgiving to you and yours.

11/19/2025

Rising PTH levels may be your body’s early warning sign of secondary hyperparathyroidism (SHPT), long before you feel symptoms. Ask your doctor about monitoring your PTH trends. https://bit.ly/48hb59K

11/18/2025

Limiting phosphorus is important when living with CKD, but that doesn’t mean you can’t enjoy the holiday favorites. Work with your care team to make choices that support both your health and the season.
https://www.hopkinsmedicine.org/health/wellness-and-prevention/low-sodium-holiday-hacks

11/13/2025

Diabetes doesn’t just affect blood sugar; it challenges your kidneys twice as much. Proactive monitoring and early disease management can help protect kidney health in individuals with diabetes.
https://bit.ly/4q8r1BN

11/11/2025

Secondary hyperparathyroidism often develops silently, putting strain on your bones, heart, and kidneys before any symptoms show up. If you’re living with CKD, ask your HCP about routine PTH monitoring.https://bit.ly/42wIYjj

10/29/2025

At OPKO Renal, our team is driven to improve the lives of people with CKD and SHPT. Innovation isn’t just about advancing science; it’s about delivering hope, education, and better patient and caregiver outcomes.

10/27/2025

Your bones are a vital reservoir for minerals like calcium and phosphorus. SHPT disrupts this delicate storage. Get tested early to monitor bone mineral balance.
https://www.ncbi.nlm.nih.gov/sites/books/NBK557822/

10/22/2025

Did you know? CKD affects women differently. Let’s ensure women receive timely, tailored CKD care.

https://pmc.ncbi.nlm.nih.gov/articles/PMC7396766/

10/20/2025

Today is World Osteoporosis Day. For patients with CKD, secondary hyperparathyroidism (SHPT) silently disrupts bone quality long before fractures. Proactive monitoring of PTH, vitamin D, calcium, and phosphorus helps preserve strength and independence.
https://bit.ly/4p1Cbri

10/09/2025

Food is more than fuel; it’s part of managing CKD and SHPT. The right balance of phosphorus, calcium, and vitamin D supports your kidneys and bones.
https://www.kidney.org/nutrition

10/06/2025

Feeling more than fall fatigue? For people with CKD, persistent tiredness may be an early sign of secondary hyperparathyroidism (SHPT). Don’t ignore the signal, talk to your care team about testing. https://bit.ly/4p5nNyb

09/29/2025

Vitamin D helps keep calcium and phosphorus in balance. In CKD, when the kidneys stop activating it, that balance tips, raising PTH and increasing SHPT risk. Learn more here: https://bit.ly/4m3DG6j

Address

4400 Biscayne Boulevard
Miami, FL
33137

Telephone

+13055754100

Website

http://www.opko.com/

Alerts

Be the first to know and let us send you an email when OPKO Renal posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Miami?